自组合在缓解胃肠病变晚期内切除后延迟出血的有效性:一个元分析
Harishankar Gopakumar1, Ishaan Vohra1, Neil R Sharma2
1Department of Gastroenterology and Hepatology, University of Illinois College of Medicine at Peoria, Peoria, Illinois, United States.
Endoscopy international open
|May 30, 2023
概括
一种新型的自组合 (SAP) 溶液有效地减少了胃肠病变的先进内镜切除后的延迟出血. 这次元分析发现SAP是安全的,没有报告的不良事件,为患者护理提供了一个有前途的选择.
科学领域:
- 胃肠病学 胃肠病学
- 内視鏡外科手術 內視鏡外科手術
- 生物材料是一种生物材料.
背景情况:
- 对于胃肠病变的先进内镜切除技术具有延迟出血 (DB) 的风险.
- 一种全新合成自组合 (SAP) 已成为减轻这种风险的潜在解决方案.
- 评估SAP在预防DB的有效性和安全性对于改善患者的治疗结果至关重要.
研究的目的:
- 进行一项元分析,评估SAP在胃肠道光线病变的先进内镜切除后减少DB的有效性.
- 分析可用研究的汇总数据,以量化DB率的降低.
- 评估SAP的安全概况,特别是寻找任何报告的不良事件 (AE).
主要方法:
- 从2010年1月到2022年10月,在主要的电子数据库 (PubMed,Embase,Cochrane图书馆) 中进行了系统的文献搜索.
- 包括涉及在接受胃肠病变先进内镜切除的患者中使用SAP溶液的研究.
- 使用固定和随机效应模型计算了DB和AE的聚合比例.
主要成果:
- 分析包括了6项研究,涉及307名患者. 汇总的DB比率为5.73%.
- 患者的平均年龄为69.40岁,平均切除病变大小为36.20毫米.
- 内镜下粘膜解剖 (72.69%) 和内镜粘膜切除 (26.42%) 是主要的程序. 36%的患者正在服用抗血栓药物.
- 没有任何不良事件归因于SAP的使用,AE的汇总率为0.00%.
结论:
- 在高风险胃肠病变的先进内镜切除后,SAP溶液在减少手术后延迟出血方面显示出显著的希望.
- 在这种情况下,SAP的使用与良好的安全性相关,没有报告的不良事件.
- SAP代表了提高先进内镜切除的安全性和有效性的潜在有价值的工具.
相关概念视频
Peptic Ulcer Disease IV: Management
118
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
118
Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents
581
In the intricate landscape of the gastric lumen, excessive acid secretion disrupts the natural defense mechanisms, weakening the mucus-bicarbonate barrier. This vulnerability allows pepsin to infiltrate epithelial cells, digesting mucosal proteins and triggering erosion, leading to ulcer formation.
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
581


